The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials
G. Fucà, Vincenzo Guarini, C. Antoniotti, F. Morano, R. Moretto, S. Corallo, F. Marmorino, S. Lonardi, L. Rimassa, A. Sartore-Bianchi, B. Borelli, M. Tampellini, S. Bustreo, Matteo Claravezza, A. Boccaccino, R. Murialdo, A. Zaniboni, G. Tomasello, F. Loupakis, V. Adamo, G. Tonini, E. Cortesi, F. de Braud, C. Cremolini, F. Pietrantonio
British Journal of Cancer